Financial statements Biokrap
Balance sheet data of BIOKRAP
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 12 957 522,10 | 13 440 248,54 | 14 148 672,53 |
| A. Fixed assets | 7 910 478,90 | 7 474 780,08 | 6 984 503,17 |
| B. Current assets | 5 047 043,20 | 5 965 468,46 | 7 164 169,36 |
| C. Share capital contributions (basic funds) | - | - | - |
| D. Own shares (stocks) | - | - | - |
| Total liabilities | 12 957 522,10 | 13 440 248,54 | 14 148 672,53 |
| A. Equity | 12 813 771,41 | 13 215 803,41 | 13 875 146,91 |
| B. Liabilities and provisions for liabilities | 143 750,69 | 224 445,13 | 273 525,62 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 143 750,69 | 224 445,13 | 273 525,62 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.